WO2004004705A3 - Pharmaceutical formulations for preparing drink products - Google Patents

Pharmaceutical formulations for preparing drink products Download PDF

Info

Publication number
WO2004004705A3
WO2004004705A3 PCT/GB2003/002866 GB0302866W WO2004004705A3 WO 2004004705 A3 WO2004004705 A3 WO 2004004705A3 GB 0302866 W GB0302866 W GB 0302866W WO 2004004705 A3 WO2004004705 A3 WO 2004004705A3
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical formulations
drink products
preparing drink
composition
preparing
Prior art date
Application number
PCT/GB2003/002866
Other languages
French (fr)
Other versions
WO2004004705A2 (en
Inventor
John Anthony Walters
Original Assignee
Shannon Biotechnology Ltd
John Anthony Walters
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0215532A external-priority patent/GB0215532D0/en
Priority claimed from GB0217130A external-priority patent/GB0217130D0/en
Priority claimed from GB0227595A external-priority patent/GB0227595D0/en
Priority claimed from GB0229315A external-priority patent/GB0229315D0/en
Priority claimed from GB0300052A external-priority patent/GB0300052D0/en
Application filed by Shannon Biotechnology Ltd, John Anthony Walters filed Critical Shannon Biotechnology Ltd
Priority to AU2003251152A priority Critical patent/AU2003251152A1/en
Publication of WO2004004705A2 publication Critical patent/WO2004004705A2/en
Publication of WO2004004705A3 publication Critical patent/WO2004004705A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Provided is a composition comprising one or more pharmaceutically active substances, a salt, and/or a protein, and/or carbohydrate, wherein the composition is capable of being dissolved or suspended in an aqueous solution to form a drink product in which the pharmaceutically active substance is suitable for storage.
PCT/GB2003/002866 2002-07-03 2003-07-03 Pharmaceutical formulations for preparing drink products WO2004004705A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003251152A AU2003251152A1 (en) 2002-07-03 2003-07-03 Pharmaceutical formulations for preparing drink products

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
GB0215532A GB0215532D0 (en) 2002-07-03 2002-07-03 Application and formula patent for process of manufacturing a ready-to-drink analgesic preparation
GB0215532.3 2002-07-03
GB0217130.4 2002-07-24
GB0217130A GB0217130D0 (en) 2002-07-24 2002-07-24 Application and formula patent for the process of manufacturing ready-to-drink analgesic preparations for sale through general sales listing
GB0227595A GB0227595D0 (en) 2002-11-26 2002-11-26 Ready to drink medicines
GB0227595.6 2002-11-26
GB0229315A GB0229315D0 (en) 2002-12-17 2002-12-17 Process leading to ready to drink formulations of aqueously insoluble medicines including ibuprofen
GB0229315.7 2002-12-17
GB0300052A GB0300052D0 (en) 2003-01-03 2003-01-03 Formulation and manufacturing of RTD using aqueously insoluble medicines with particular respect to article size
GB0300052.8 2003-01-03

Publications (2)

Publication Number Publication Date
WO2004004705A2 WO2004004705A2 (en) 2004-01-15
WO2004004705A3 true WO2004004705A3 (en) 2004-03-11

Family

ID=30119379

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2003/002866 WO2004004705A2 (en) 2002-07-03 2003-07-03 Pharmaceutical formulations for preparing drink products

Country Status (2)

Country Link
AU (1) AU2003251152A1 (en)
WO (1) WO2004004705A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8216610B2 (en) 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2566331C (en) * 2004-05-28 2011-03-15 Imaginot Pty Ltd. Oral delivery system
PE20060484A1 (en) * 2004-07-14 2006-07-06 Ucb Farchim Sa LIQUID PHARMACEUTICAL PREPARATIONS CONTAINING A BENZHYDRIL PIPERIZINE COMPOUND
AU2006317530B2 (en) 2005-11-28 2011-09-01 Imaginot Pty Ltd Oral therapeutic compound delivery system
US20070190130A1 (en) * 2006-02-16 2007-08-16 Mark William A Protein hydrolysate excipients
AU2006346318B2 (en) 2006-07-18 2011-02-10 Genfarma Laboratorio S.L. Injectable liquid paracetamol formulation
FR3041967B1 (en) * 2015-10-01 2020-10-16 Ass F I D O P COMPOSITION CONTAINING A GRIND OF PLANTS AND MALTODEXTRIN
CA3079245A1 (en) * 2017-07-13 2019-03-21 Tab Protein, Llc Supplement tablet and packaging

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4361580A (en) * 1980-06-20 1982-11-30 The Upjohn Manufacturing Company Aluminum ibuprofen pharmaceutical suspensions
EP0670160A1 (en) * 1994-03-01 1995-09-06 Gerhard Dr. Gergely Granular product or tablet containing an effervescent system and an active pharmaceutical substance, as well as a method for its preparation
RU2056772C1 (en) * 1993-06-30 1996-03-27 Владимир Борисович Спиричев Method of preparing dry mixture for nonalcoholic beverage or cocktail and dry mixture for nonalcoholic beverage or cocktail
WO1999026856A1 (en) * 1997-11-21 1999-06-03 Katsikas, Marios Use of dual compartment mixing container for enzyme mixtures useful to treat acne
DE19847968A1 (en) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Separate storage of an active material and a solvent comprises a closure cap and a container, with a chamber attached to the unit.
WO2001093692A2 (en) * 2000-06-06 2001-12-13 Patrone, Atilio New canine beverage
US20030118654A1 (en) * 2001-12-07 2003-06-26 B. Santos Joyce Bedelia Taste masked aqueous liquid pharmaceutical composition

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4361580A (en) * 1980-06-20 1982-11-30 The Upjohn Manufacturing Company Aluminum ibuprofen pharmaceutical suspensions
RU2056772C1 (en) * 1993-06-30 1996-03-27 Владимир Борисович Спиричев Method of preparing dry mixture for nonalcoholic beverage or cocktail and dry mixture for nonalcoholic beverage or cocktail
EP0670160A1 (en) * 1994-03-01 1995-09-06 Gerhard Dr. Gergely Granular product or tablet containing an effervescent system and an active pharmaceutical substance, as well as a method for its preparation
WO1999026856A1 (en) * 1997-11-21 1999-06-03 Katsikas, Marios Use of dual compartment mixing container for enzyme mixtures useful to treat acne
DE19847968A1 (en) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Separate storage of an active material and a solvent comprises a closure cap and a container, with a chamber attached to the unit.
WO2001093692A2 (en) * 2000-06-06 2001-12-13 Patrone, Atilio New canine beverage
US20030118654A1 (en) * 2001-12-07 2003-06-26 B. Santos Joyce Bedelia Taste masked aqueous liquid pharmaceutical composition

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8216610B2 (en) 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations

Also Published As

Publication number Publication date
AU2003251152A1 (en) 2004-01-23
WO2004004705A2 (en) 2004-01-15

Similar Documents

Publication Publication Date Title
CA2481848A1 (en) Active ingredient particles carrying clopidogrel or a salt thereof, their use and method of preparation
AU1030501A (en) Microcapsules for stabilizing cosmetic, pharmaceutical or food products
UY26372A1 (en) "IMIDAZO-3-IL-AMINAS BICÍCLICAS PROCEDURE FOR ITS PREPARATION AND DRUGS THAT CONTAIN THEM"
AU2001278771A1 (en) Carboxylic acid derivatives, process for producing the same and drugs containingthe same as the active ingredient
AU2002243005A1 (en) Vital cell preparations containing lactic acid bacterium as the active ingredient and lactic acid bacterium-containing foods
EP1327448A4 (en) Homeostasis-maintaining agents
GB2443793B (en) Product, method of manufacture and use
WO2006103672A3 (en) Spherically shaped substances
WO2004004705A3 (en) Pharmaceutical formulations for preparing drink products
AU2001278772A1 (en) Benzoic acid derivatives and drugs containing the same as the active ingredient
AU2003246567A1 (en) Administration form for the oral administration of active substances, vitamins, and/or nutrients
WO2004017943A3 (en) Non-vesicular cationic lipid formulations
WO2001045650A3 (en) Cosmetic use of the residues from wine production
AU3669700A (en) 4-aminobutanoic acid derivatives and drugs containing these derivatives as the active ingredient
AU2001282730A1 (en) Seal-oil-based pharmaceutical, cosmetic, dermo-cosmetic, hygiene, alimentary andpara-alimentary (food-supplements) products; their methods of preparation; thei r uses as preventive and/or as therapeutic agents
UA89349C2 (en) Uncoated tablet containing olanzapine and a process for preparing thereof
WO2005012210A3 (en) Antimicrobial active preparations containing terpene derivatives
WO2002000208A3 (en) Combination preparations of 3-n-formylhydroxylaminopropyl phosphonic acid derivatives or 3-n-acetylhydroxylaminopropyl phosphonic acid derivatives combined with specific pharmaceutical active agents
AU2003246566A1 (en) Administration form for the oral administration of active substances, vitamins, and/or nutrients
HUP0402093A3 (en) 3-phenyl-2-phenethylthio-propionic acid derivatives as selective agonists of ppar-alpha, their preparation and pharmaceutical compositions containing them
ATE245974T1 (en) PHARMACEUTICAL COMPOSITIONS INTENDED FOR THE ORAL ADMINISTRATION OF PHLOROGLUCINOL AND THE PRODUCTION THEREOF
ID26543A (en) SINGLE DOSAGE BOTTLE FOR DRINK LIQUID, ESPECIALLY FOR PHARMACEUTICAL PRODUCTS
NO20023249D0 (en) New Substituted Pyrazolo (4,3-e) Ediazepines, Pharmaceutical Preparations Containing These, Use as Medical Products and Methods for Preparing Them
AU7393901A (en) Glycoside esters, the production and the use thereof in cosmetics, pharmaceutical products and foodstuff or animal feed
HUP0203161A3 (en) Benzamidine derivatives, process for their preparation and pharmaceutical compositions containing them and their use

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
712F Gb: determination of foreign entitlement (section 12(1)/1977)

Free format text: REFERENCE UNDER SECTION 12 DECIDED BY THE COMPTROLLER

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP